Market Research Report

  The market for oculopharyngeal muscular dystrophy (OPMD) market was estimated to be worth 4.9 billion in 2024, and a compound annual growth rate (CAGR) of 16.1% is anticipated over the course of the projected period. The market is expanding rapidly due to the increased incidence of diabetes and obesity. Consequently, the market is expanding due to muscle illnesses worldwide. It causes vision problems and makes swallowing more challenging. The growing number of glaucoma patients is propelling the market's notable expansion due to the rising incidence of eye conditions and the aging of the world's population. The market is expanding due to advancements in tonometry equipment, the creation of tonometers, and a growing focus on enhancing patient comfort, efficacy, and usability. The creation and distribution of preservative solutions used in ophthalmic drugs and their treatment are the main areas of interest for OPMD. For eye drops and other associated goods to be safe and eff...